Answers are grounded in this paper and cite their sources.
A newly identified protein — heme carrier protein 1 — apparently mediates the uptake of cellular heme. Mutations impairing the activity of this protein might account, in part, for the broad spectrum of clinical severity observed in patients with genetic hemochromatosis.
No takes yet. Share an insight, caveat, or question.
Nancy C. Andrews (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: